GlassScriptPhysician profile
Anya Turetsky
NPI 1497040315
$1,608.05
in general payments reported to CMS, 2019-2025
22 companies · $249 in 2025
The $249 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,108 · 2020: $251 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $158.82 | 2019-2020 | |
| Ucb, INC. | $149.87 | 2019-2025 | Rystiggo |
| Novartis Pharmaceuticals Corporation | $122.52 | 2019 | |
| Eisai INC. | $121.12 | 2025 | |
| Acorda Therapeutics, INC | $112.83 | 2019-2020 | |
| Genzyme Corporation | $100.01 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $94.80 | 2019-2020 | |
| Biogen, INC. | $91.51 | 2019 | |
| Avanir Pharmaceuticals, INC. | $68.45 | 2019 | |
| Lilly USA, LLC | $68.27 | 2019-2020 | |
| Allergan, INC. | $65.89 | 2019-2020 | |
| Mdd US Operations, LLC | $65.65 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $59.53 | 2019 | |
| Alexion Pharmaceuticals, INC. | $56.12 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $53.32 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $51.62 | 2019 | |
| Vertical Pharmaceuticals, LLC | $43.92 | 2019-2020 | |
| Tanabe Pharma America, INC. | $36.75 | 2019 | |
| Neurocrine Biosciences, INC. | $36.65 | 2019-2020 | |
| Strongbridge US INC. | $18.40 | 2019 | |
| Kyowa Kirin, INC. | $17.73 | 2019 | |
| Grifols USA, LLC | $14.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anya Turetsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.